Radius Health Inc logo

RDUS - Radius Health Inc News Story

$12.04 -0.5  -4.1%

Last Trade - 18/09/20

Mid Cap
Market Cap £433.2m
Enterprise Value £501.8m
Revenue £155.2m
Position in Universe 2869th / 6396

BUZZ-Small/Mid-Cap Biotech: Morgan Stanley highlights Radius Health, Sage Therapeutics

Wed 21st March, 2018 10:49am
** Morgan Stanley highlights Radius Health  RDUS.O , Sage
Therapeutics  SAGE.O  and Biomarin Pharmaceuticals  BMRN.O  as
key "overweights", cites clear catalysts ahead
    ** Raises PT on Beigene to $200 from $93; Bluebird to $209
from $152
    ** Sarepta Therapeutics Inc  SRPT.O , Loxo Oncology Inc
 LOXO.O  and Global Blood Therapeutics Inc  GBT.O  cut to "equal
weight" from "overweight" by Morgan Stanley 
    ** MS downgrades SRPT as the next move higher will be driven
by success in genetherapy where MS says doesn't have an edge in
calling the outcome, but raises PT to $87 from $64 
    ** YTD S&P 500 - Biotechnology Sub Index up 135 pct

 (Reporting by Abdul Nishad  C K)
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.